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INCIDENCE OF CONGENITAL TOXOPLASMOSIS IN SOUTHERN BRAZIL: A PROSPECTIVE STUDY
Liége MOZZATTO(1) & Renato SOIBELMANN PROCIANOY(2)
SUMMARY
The study aimed to determine the incidence of congenital infection by Toxoplasma gondii and to describe neonatal and maternal
characteristics regarding newborn infants treated at a teaching hospital in the town of Passo Fundo, State of Rio Grande do Sul, Brazil.
Cord blood samples collected from 1,250 live newborns were analyzed. The laboratory diagnosis was established by the detection of
Toxoplasma gondii IgM using an enzyme linked fluorescent assay. Gestational age, intrauterine growth, anthropometric measures,
and prenatal characteristics were assessed. The incidence of congenital toxoplasmosis at birth was 8/10,000 (95%CI 0.2-44.5). Mean
birthweight was 3,080 ± 215.56 grams and mean gestational age was 38.43 ± 1.88 weeks. With regard to prenatal care, 58% of the
pregnant patients visited their doctors five times or more and 38.9% were serologically tested for toxoplasmosis in the first trimester
of pregnancy. The incidence of congenital toxoplasmosis was similar to that found in most studies conducted in our country and
abroad. Our study sample is representative of the town of Passo Fundo and therefore it is possible to consider the frequency observed
as the prevalence of the disease in this town during the study period.
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INTRODUCTION
Toxoplasmosis is a ubiquitous zoonosis caused by Toxoplasma
gondii. The disease was discovered by Splendore, in Brazil, and Nicolle
and Manceaux, in Tunisia, in 1908. In 1923, Janku described the
congenital form of the disease in an infant with hydrocephalus and
microphthalmia25. Individuals usually get infected consuming
contaminated water and food containing oocysts, or by ingesting
uncooked or undercooked meat containing tissue cysts. Other forms of
transmission include blood transfusions, organ transplantation and
laboratory accidents. Fetal transmission occurs hematogenously through
the placenta9,25.
Fetal involvement results from acute infection in the mother; however,
those mothers with chronic infection can transmit the disease by
reactivation, which is caused by an immunological dysfunction4,25. The
rate of fetal transmission during primoinfection is 25%, 54% and 65%,
in the first, second and third trimesters, respectively9. The treatment of
pregnant women is believed to prevent serious sequelae in newborn
infants, but does not prevent fetal transmission; therefore, the outcome
is certainly better the earlier the treatment23.
‘The severity of the disease is inversely proportional to gestational
age. Fetal involvement is more severe when mothers get infected at the
beginning of pregnancy. If transmission occurs after the 30th week up to
term, the forms of the disease are milder9. The clinical status varies
enormously. Approximately two thirds of newborn infants are
asymptomatic at birth, but can develop sequelae, such as microcephalia,
hydrocephalus, chorioretinitis, uveitis, deafness and delayed
psychomotor development, at a later time28. The classical tetrad of
hydrocephalus, chorioretinitis, intracranial calcifications and mental
retardation is not necessarily present in all cases. REMINGTON et al.25
have classified the disease into four forms: subclinical infection, neonatal
disease, disease in the first months of life, and sequelae.
Serological tests, especially immunoenzyme assays, are the routine
exams for the diagnosis of the disease. The detection of IgM and/or IgA
and/or IgE anti-toxoplasma antibodies in cord blood or in the newborn’s
blood establishes the diagnosis9,16,28. Also, it is possible to detect the
parasite in body fluids by isolating it in tissue culture or by inoculation
into mice, by the detection of parasitic antigens and toxoplasma DNA
using the polymerase chain reaction (PCR)9,28.
The treatment of congenitally infected infants with pyrimethamine,
sulfadiazine and folinic acid, implemented within the first month of life
and extended for the first year of life, improves the prognosis, reducing
the frequency and severity of later sequelae. Late diagnosis and delayed
treatment implementation contribute to remarkable disabilities13.
The incidence of congenital toxoplasmosis in Passo Fundo is still
unknown. Dwellers of this town ingest large amounts of meat, with rates
similar to the those of the neighboring town of Erechim, which is known
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for the high frequency of congenital toxoplasmosis26. In 2001, 45% of
pregnant women living in Passo Fundo did not have prenatal care or
received it in an inadequate manner. This hinders the identification of
pregnant women at risk for toxoplasmosis.
The aim of the present study was to determine the incidence of
congenital toxoplasmosis at birth in the town of Passo Fundo and to
describe neonatal and maternal variables.
MATERIAL AND METHODS
This incidence study was carried out at Hospital São Vicente de
Paula, in Passo Fundo, state of Rio Grande do Sul. The analysis of cord
blood was conducted at the Lavoisier-Labcenter Laboratory, located in
the same town. The screening for Toxoplasma gondii DNA in blood and
cerebrospinal fluid (CSF) was performed at the DNA Reference
laboratory, in Porto Alegre, the state capital. The study was approved by
the Scientific and Ethics Committees of the Graduate Research Group
of Hospital de Clínicas de Porto Alegre and of Hospital São Vicente de
Paula in Passo Fundo.
After consent by the assisting physician and written consent by the
patient and her family at admission to the maternity ward, all live
newborns were included in the study. After delivery and after birth, 2 ml
of cord blood were collected. The samples were centrifuged for 5 minutes
at 3,500 rpm, separated, quantitated and stored at -20 °C until later
analysis. The serum obtained was screened for IgM anti-toxoplasma
antibodies using the Enzyme Linked Fluorescent Assay (ELFA) in the
mini VIDAS system (BioMérieux). ELFA is an IgM capture test with a
final detection in fluorescence, with the following indices: i < 0.55,
negative; i ≥ 0.65, positive and 0.55 ≤ i < 0.65, undetermined. A positive
and a negative control were used for recalibration of the device and for
the confirmation that reagents were unaltered whenever a new
MINIVIDAS TOXO IgM kit was opened.
Next, a questionnaire for the mother/newborn characteristics was
filled out, with the following material data: age, socioeconomic status,
years spent in school, marital status, number of prenatal consultations,
serological tests for toxoplasmosis every three months, type of serological
test used, treatment against toxoplasmosis during pregnancy, ingestion
of uncooked or undercooked meat, ingestion of unpasteurized milk,
uncooked eggs, and presence of cats at home or in the workplace. The
data collected for the newborn were the following: weight, gestational
age, intrauterine growth, length and head and chest circumference at
birth. Aside from the interview, information contained in the prenatal
records was used. The socioeconomic status was determined by the
Economic Classification of the Brazilian Population1. The anthropometric
measures were obtained according to the recommended techniques,
gestational age was determined by the method of CAPURRO et al.6,
and intrauterine growth was assessed by the curve of BATTAGLIA &
LUBCHENCO3.
The protocol included the collection of peripheral venous blood (2
ml in a vacutainer with EDTA) for every newborn infant who tested
positive for IgM. In addition, 30 drops of CSF were collected for the
investigation of toxoplasma DNA by PCR, for follow-up of IgM titers
during neonatal treatment and for the collection of blood from the mother
for the quantitation of anti-toxoplasma IgM (ELFA). The salting-out
and GFXTM Genomic Blood DNA Purification methods were used for
the extraction of DNA from blood and cerebrospinal fluid, respectively.
Nested DNA amplification was also employed.
The sample size was calculated as 1,195 newborns considering an
incidence of approximately five cases/1,000 live births and a 95% CI.
The population rate was estimated by the 95% CI based upon binomial
distribution. Neonatal and maternal variables were categorized by simple
frequency tables. The mean and standard deviation were calculated for
some variables.
RESULTS
Between July 2001 and February 2002, 1,250 cord blood samples
were collected. One newborn infant tested positive for IgM at birth (i =
10.13), showed subclinical infection. On the examination of the ocular
fundus under mydriasis, the newborn showed bilateral cicatricial
chorioretinitis in the temporal region, and the CSF analysis revealed 65
mm³ cells, 24% neutrophils, 76% monocytes, 0% eosinophils, 23 mg%
glucose, 109 mg% proteins, and ++ globulins. The incidence of
congenital toxoplasmosis was 8/10,000 (95% CI 0.2-44.5). The
serological test was repeated in infected newborns on the 5th, 30th, 60th,
90th and 120th days, with respective results of: 10.10, 8.22, 1.8, 0.95
and 0.43. PCR in venous peripheral blood and in CSF was negative. The
quantitation of IgM of seropositive mothers was 4.55.
The mean weight and the mean gestational age of the studied sample
were 3,080 ± 215.56 grams and 38.43 ± 1.88 weeks. The intrauterine
growth of most newborns (72%) was adequate for gestational age and
22.9% of them were below the 10th percentile on the growth curve.
Among these, 15.3% were preterm and 7.6% full-term babies. Length,
and head and chest circumference are shown in Table 1.
The age of pregnant women ranged from 13 to 46 years (mean 25.6
± 6.9) and the mean time spent in school was 8.3 ± 2.9 years. The
distribution in terms of socioeconomic status and marital status is shown
in Table 2. Table 3 shows the eating habits and contact with cats.
Table 1
General characteristics of 1250 infants born in Passo Fundo (RS) between
July 2001 and February 2002 regarding weight, gestational age, length and
head and chest circumference
Variables n %
Birthweight (g)¹ 3,080 ± 215.56
< 1,500  35 (2.8)
1,500 – 2,499  311 (24.9)
2,500 – 3,999  829 (66.3)
> 4,000  75 (6.0)
Gestational age (weeks)¹ 38.43 ± 1.88
< 37  208 (16.7)
37 – 42  1,038 (83.0)
> 42  4 (0.3)
Length (cm)¹ 48.5 ± 1.1
Head circumference (cm)¹ 34.2 ± 1.7
Chest circumference (cm)¹ 32.3 ± 1.3
 1 Values expressed as mean and standard deviation
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Only 3.4% of pregnant patients did not receive any prenatal care,
whereas 58% visited their doctors more than five times. Of 1,250 pregnant
women, 1,001 were tested at least once for toxoplasmosis during the
prenatal period, 187 were not submitted to any test, 62 did not know
whether they had been serologically tested, and 498 pregnant patients
were submitted to more than one serological test during pregnancy. The
distribution of the number of pregnant women who were submitted to
antitoxoplasma serology per gestational trimester was: 486 in the first,
515 in the second, and 444 in the third trimester. The following serological
tests were requested: indirect immunofluorescence (61.3%), MEIA
(12.6%) and ELFA (6.2%).
The incidence of toxoplasma IgG and IgM in pregnant women was
48.5% (95% CI 46-51%) and 0.6% (95% CI 0.3-8), respectively.
Six pregnant women received spiramycin and one HIV-positive
pregnant patient received pyrimethamine, sulfadiazine and folinic acid
during prenatal care. All the infants born to these mothers tested negative
for IgM-toxoplasma and none showed any disorder on physical
examination at birth.
During the study period, there were 1,735 deliveries in the four town
hospitals, of which 1,257 (72.5%) occurred at Hospital São Vicente de
Paula. Seven losses occurred during the study, five of which included
newborn infants delivered by women who had toxoplasmosis tests during
gestation, and none of the newborns showed any disorder on physical
examination. The distribution of the study population according to the
Economic Classification of the Brazilian Population was as follows: A1
(0.6%), A2 (3.0%), B1 (4.6%), B2 (7.3%), C (30.9%), D (42.3%), E
(11.3%).
DISCUSSION
Analysis of the results obtained showed that the incidence of
congenital toxoplasmosis in the study population was similar to that
reported in other studies, ranging from 0 to 100/10,000 live births,
according to socioeconomic, cultural, ethnic, and climatic factors of the
study population and to the type of parasite strain9,14. The incidence of
the disease per 10,000 births was 7 in New York, 53 in Germany, 86 in
Austria and 30 in Paris, where pregnant women are at a high risk for
toxoplasmosis9. Some Brazilian studies have revealed frequencies
between 2 and 20/10,000 live births17,18,21, but a study carried out in the
state of Pernambuco indicated a high frequency in newborns from mothers
with primoinfection, 1,250/10,000 live births (95%CI 3.5-29%)20. In
these studies, however, the serological methods were different, with some
variability in terms of specificity, sensitivity, and positive and negative
predictive values. A program for neonatal screening for the detection of
IgM-toxoplasma antibodies, Enzyme Immunoassay (EIA), was
implemented in Porto Alegre by the Center for Neonatal Screening and
Nobel RIE Laboratory, and tested between 1995 and 1996. The
approximate incidence in the State was two cases per 10,000 live births17.
This finding may not represent the actual frequency of the disease, since
not all newborns are submitted to neonatal screening for toxoplasma
antibodies19 and also because the method used has a sensitivity of 61.2%
and a specificity of 88.8%24.
The present study was conducted at a hospital that handles most
deliveries in the town of Passo Fundo and attends pregnant women from
all socioeconomic classes, according to the data of the Municipal
Department of Health.
The distribution of the study population according to the Economic
Classification of the Brazilian Population was similar to that of Passo
Fundo, and is classified as: A1-0.5%, A2-4.5%, B1-8.3%, B2-13.2%,
C-46%, D-22.5%, E-5%. In addition, during the study, 72.5% of births
in the town took place at Hospital São Vicente de Paula. Our study sample
can be considered to be representative of pregnant women in the town of
Passo Fundo during the study period. Our results can therefore be
considered to correspond to the prevalence of congenital toxoplasmosis
in the town of Passo Fundo during the study period.
Three factors that influence primoinfection in pregnant women should
be taken into consideration in order to explain the incidence rate in a
given population. First, the incidence of infection in the community;
secondly, the frequency of possible contacts with sources of infection;
and thirdly, the number of women of childbearing age who have not had
primoinfection yet25. In some regions of the state, the rate of toxoplasma
infection was higher (86%)15, than that found in most studies conducted
in our country. Nevertheless, the highest incidence of congenital
toxoplasmosis in Erechim (2.1%)26 might result from a more intense
Table 3
Characteristics of pregnant patients who gave birth to 1250 infants in Passo
Fundo (RS) between July 2001 and February 2002 regarding eating habits
and contact with cats
Variables n %
Contact with cats  696 (55.7)
Ingestion of undercooked meat  463 (37.0)
Ingestion of uncooked meat  791 (63.3)
Ingestion of unpasteurized milk  504 (40.3)
Ingestion of uncooked eggs  960 (76.8)
Table 2
Characteristics of pregnant patients who gave birth to 1250 infants in Passo
Fundo (RS), between July 2001 and February 2002 regarding socioeconomic
status and marital status
Variables n %
Socioeconomic status
A1  7 (0.6)
A2  37 (3.0)
B1  58 (4.6)
B2  91 (7.3)
C 386 (30.9)
D 530 (42.3)
E  141 (11.3)
Marital status
Single  170 (13.6)
Married  458 (36.6)
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and chronic exposure of mothers to the parasite than elsewhere27, in
addition to the fact that type I strains are more virulent and frequent in
town14. MELAMED et al.15 have underscored the high differentiation of
the seropositivity of the disease, even in nearby regions.
In our environment, neither the prevalence of toxoplasma infection
in the community nor the frequency of susceptible pregnant women in
the first prenatal consultation (seronegative) is known. This consultation
could identify pregnant women at higher risk for fetal transmission of
toxoplasmosis at the beginning of pregnancy. In this study, 702 (56.2%)
pregnant patients were not serologically tested during their first trimester
of pregnancy and 62 women did not know about the serological exam.
NAESSENS et al.16 have assessed the sensitivity and specificity of
the tests with titers of IgM and IgA in blood samples and cord blood
samples collected from newborns. Sensitivity was similar and the total
specificity of tests with neonatal blood was better than that of tests with
cord blood: specificity of IgM and IgA in neonatal blood is 99%, whereas
the specificity in cord blood is 96% and 92%, respectively. Nevertheless,
we opted for cord blood due to the sample size needed and also to avoid
invasive procedures.
We tested the IgM antibody since it does not usually cross the placenta
at any time during pregnancy (except for placentitis); being used as the
basis for the diagnosis of congenital infection25. Nevertheless, the screening
for IgA is more sensitive4,16,25, but its specificity is limited due to the greater
possibility of passive transfer of antibodies from the mother25. On the
other hand, the detection of segments of the parasite by PCR is regarded
as diagnostic25. Despite the high sensitivity of this test25, BASTIEN2
believes that the PCR does not have sufficient sensitivity for toxoplasma.
There is, however, no doubt about its benefits for diagnosis. FUENTES et
al.10 have detected Toxoplasma gondii by PCR in the blood and CSF of
three out of four newborns with congenital infection.
The serological method chosen in this research is due to the fact that
this technique includes a capture IgM. This eliminates the interference
of a specific IgG, which causes false-negative results, and the interference
of the rheumatoid factor and of antinuclear antibodies, which cause false-
positive results, in most cases. ELFA has high sensitivity and specificity,
ranging between 93.5% and 99.3%, respectively. WILSON et al.29 have
assessed six commercially available tests and found a sensitivity and
specificity of 100% and 98.6%, respectively, for VIDAS Toxo IgM. The
rate of equivocal results was 0.9%. The most cost-effective methods are
those with a better combination of sensitivity and specificity and few
equivocal results29. PELLOUX et al.22 have found a sensitivity of 100%
and a specificity of 97% for this method. An assessment of four diagnostic
methods for the detection of IgM-toxoplasma has shown discrepancy
between tests, indicating that it is important to consider the prevalence
of the disease in the population to which these tests are to be applied.
ELFA was the most specific test with the highest negative predictive
value, 99.3% and 98.7%, respectively11. Therefore, we can say that this
laboratory test proved to be adequate for our key objective, since a
sensitivity of 100% and a high negative predictive value are desirable
when attempting to identify infected newborns8.
As the incidence of congenital toxoplasmosis estimated in this study
was low, the negative predictive value of the test used by us was high8.
Therefore, the probability of false-negative results was minimal, whereas
that of false-positives would be greater, since the test-positive newborn
showed signs of the disease. This, however, did not occur in our study.
NAESSENS et al.16 have stated that early-infected infants are less
frequently positive for IgM and IgA at birth due to the lack of immune
response of the fetus before 20-22 weeks of gestation and to the short
duration of this response. Studies that include infants infected before 20
weeks can have less sensitivity to the test than studies in which infants
become infected at a later time16.
The incidence of serum positivity (IgG) in pregnant women in the
population studied may be compared to the levels found in countries
with very high risk of toxoplasmosis, such as France25. It should be
underscored that mothers received prenatal care in different places and
that serologic tests were carried out using distinct methods.
Some eating habits observed in the study have been reported in
surveys carried out to determine risk factors for toxoplasma infection in
pregnant women. According to COOK et al.7, the main risk factor was
the ingestion of uncooked meat (30%) or undercooked meat (63%), as
well as the ingestion of unpasteurized milk. KAPPERUD et al.12 have
observed that the patients with infection during pregnancy had had daily
contact with cats at a higher frequency than the controls (OR = 3.6).
These authors suggest case-control studies for the identification of the
major risk factors in different populations, with the aim of prioritizing
the guidelines for the prevention of acute infection in pregnant women12.
We believe that the screening for capture IgM (ELFA) in cord blood
is an important tool for the detection of newborns probably infected
with Toxoplasma gondii, given its relatively low cost compared to more
sophisticated methods and due to its accuracy as well5. In a situation in
which the frequency of clinical manifestations at birth is low and the
serological data of mothers are not always available, it is essential to
establish an early diagnosis and also to offer infected infants proper
treatment.5
RESUMO
Incidência de toxoplasmose congênita no sul do Brasil: estudo
prospectivo
O objetivo do estudo foi determinar a incidência de infecção
congênita pelo Toxoplasma gondii e descrever características neonatais
e maternas, em recém-nascidos atendidos num Hospital Universitário
de Passo Fundo, RS.
Foram analisadas amostras de sangue do cordão umbilical de 1250
recém-nascidos vivos. O diagnóstico laboratorial foi realizado através
da detecção de IgM-Toxoplasma gondii pelo método ELFA (Enzyme
Linked Fluorescent Assay). Avaliou-se a idade gestacional, o crescimento
intra-uterino, as medidas antropométricas e características do pré-natal.
A incidência de toxoplasmose congênita ao nascimento foi de 8/
10.000 (IC 95% 0,2 - 44,5). A média do peso de nascimento e idade
gestacional foi 3080 ± 215,56 gramas e 38,43 ± 1,88 semanas,
respectivamente. Em relação ao pré-natal, 58% das gestantes realizaram
5 ou mais consultas e, 38,9% realizaram sorologia para toxoplasmose
no 1o trimestre da gestação.
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Observou-se incidência de infecção congênita ao toxoplasma similar
à encontrada na maioria dos estudos realizados no país e exterior. A
amostra estudada é representativa da cidade de Passo Fundo, portanto,
considera-se que a frequência encontrada, seja a incidência da doença
na cidade durante o período do estudo.
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